[
    [
        {
            "time": "2018-03-15",
            "original_text": "Buy-Ranked Large Cap Pharma Stocks to Boost Your Portfolio",
            "features": {
                "keywords": [
                    "Buy-Ranked",
                    "Large Cap",
                    "Pharma Stocks",
                    "Boost Portfolio"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "pharmaceuticals"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "Buy-Ranked Large Cap Pharma Stocks to Boost Your Portfolio",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 5,
                "Duration": 4,
                "Entity_Density": 3,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2018-04-10",
            "original_text": "Novo to invest $165m in first ‘superbug’ venture fund",
            "features": {
                "keywords": [
                    "Novo",
                    "invest",
                    "$165m",
                    "superbug",
                    "venture fund"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Novo to invest $165m in first ‘superbug’ venture fund",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        },
        {
            "time": "2018-04-10",
            "original_text": "Novo Holdings launches $165 million 'superbug' drug venture fund",
            "features": {
                "keywords": [
                    "Novo Holdings",
                    "launches",
                    "$165 million",
                    "superbug",
                    "drug",
                    "venture fund"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare",
                    "biotech"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Novo Holdings launches $165 million 'superbug' drug venture fund",
                "Correlation": 10,
                "Sentiment": 9,
                "Importance": 10,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 9
            }
        }
    ]
]